Subscribe: Latest / All - Designed by Dr James P Howard (Google+)
ASCERT TRIAL |
|
|---|---|
| Problem | 2 or 3VD |
| Format | Retrospective multi-center |
| Treatment | PCI or CABG |
| Control | N/A |
| Population | 189,793 patients |
| Inclusion criteria | CABG or PCI with hospital discharge dates between January 1, 2004, and December 31, 2007 From sites participating in both the ACCF PCI database (CathPCI Registry) and the STS Adult Cardiac Surgery Database (ACD) |
| Exclusion criteria | Single-vessel disease Left main coronary artery disease Cardiogenic shock within 24 hours before CABG or at the time of admission to the hospital for PCI Myocardial infarction within 7 days before CABG or before admission to the hospital for PCI Insertion of an intraaortic balloon pump before either procedure CABG or valve surgery or PCI within 180 days before the current admission |
| Follow-up | Median 2.67 years |
| Primary endpoint | All-cause mortality |
| Secondary endpoint(s) | - |
| Details | . |
| Brief summary: | Retrospective study showing CABG superior to PCI in 2-3VD at 4 years |
| PAPER: Comparative Effectiveness of Revascularization Strategies. | |
|---|---|
| Date | 2 Apr 2012 |
| Journal | N Engl J Med. 2012 Mar 27. [Epub ahead of print] |
| Information | PCI vs. CABG in 2 or 3 vessel disease -Huge retrospective study controlling for confounding At 1 year -No significant difference in ACM (RR 0.95) At 4 years -All-cause mortality lower for CABG (RR 0.79) |